Vanda Pharmaceuticals Inc. (VNDA) stock
VNDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 10/3055% below fair value
$3.81+0.00 (0.00%)
Close on Nov 17, 2026Market cap $230.39MP/E –Yield –
Vanda Pharmaceuticals operating margin
Operating margin is operating income as a percentage of revenue.
Vanda Pharmaceuticals's operating margin for the twelve months ending Sep 30, 2026 was -77.6%. For fiscal 2025 it was -70.0%, against -20.5% the year before. The highest annual figure on record is 40.0% in fiscal 2014.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -70.0% | −49.5 |
| FY2024 | Dec 31, 2024 | -20.5% | −13.2 |
| FY2023 | Dec 31, 2023 | -7.2% | −9.7 |
| FY2022 | Dec 31, 2022 | 2.5% | −13.2 |
| FY2021 | Dec 31, 2021 | 15.7% | +4.7 |
| FY2020 | Dec 31, 2020 | 11.0% | +0.9 |
| FY2019 | Dec 31, 2019 | 10.0% | −1.2 |
| FY2018 | Dec 31, 2018 | 11.3% | +21.5 |
| FY2017 | Dec 31, 2017 | -10.2% | +2.5 |
| FY2016 | Dec 31, 2016 | -12.7% | +23.8 |
| FY2015 | Dec 31, 2015 | -36.6% | −76.6 |
| FY2014 | Dec 31, 2014 | 40.0% | +102.6 |
| FY2013 | Dec 31, 2013 | -62.6% | +26.6 |
| FY2012 | Dec 31, 2012 | -89.2% | −54.9 |
| FY2011 | Dec 31, 2011 | -34.2% | −59.0 |
| FY2010 | Dec 31, 2010 | 24.8% | +815.2 |
| FY2009 | Dec 31, 2009 | -790.4% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -33.7% | +21.9 |
| Q2 FY2026 | Jun 30, 2026 | -126.3% | −53.1 |
| Q1 FY2026 | Mar 31, 2026 | -97.1% | −15.1 |
| Q4 FY2025 | Dec 31, 2025 | -70.5% | −51.2 |
| Q3 FY2025 | Sep 30, 2025 | -55.6% | −32.5 |
| Q2 FY2025 | Jun 30, 2025 | -73.2% | −53.1 |
| Q1 FY2025 | Mar 31, 2025 | -82.0% | −62.5 |
| Q4 FY2024 | Dec 31, 2024 | -19.3% | −3.7 |
| Q3 FY2024 | Sep 30, 2024 | -23.1% | −7.6 |
| Q2 FY2024 | Jun 30, 2024 | -20.1% | −13.9 |
| Q1 FY2024 | Mar 31, 2024 | -19.5% | −22.7 |
| Q4 FY2023 | Dec 31, 2023 | -15.7% | −26.0 |
| Q3 FY2023 | Sep 30, 2023 | -15.4% | −21.4 |
| Q2 FY2023 | Jun 30, 2023 | -6.2% | −11.6 |
| Q1 FY2023 | Mar 31, 2023 | 3.2% | +15.9 |
| Q4 FY2022 | Dec 31, 2022 | 10.3% | −2.4 |
| Q3 FY2022 | Sep 30, 2022 | 6.0% | −9.5 |
| Q2 FY2022 | Jun 30, 2022 | 5.4% | −12.8 |
| Q1 FY2022 | Mar 31, 2022 | -12.7% | −29.2 |
| Q4 FY2021 | Dec 31, 2021 | 12.7% | −2.8 |
| Q3 FY2021 | Sep 30, 2021 | 15.4% | +2.6 |
| Q2 FY2021 | Jun 30, 2021 | 18.2% | +3.5 |
| Q1 FY2021 | Mar 31, 2021 | 16.5% | +16.7 |
| Q4 FY2020 | Dec 31, 2020 | 15.4% | +8.5 |
| Q3 FY2020 | Sep 30, 2020 | 12.8% | −5.2 |
| Q2 FY2020 | Jun 30, 2020 | 14.7% | −2.0 |
| Q1 FY2020 | Mar 31, 2020 | -0.2% | +4.2 |
| Q4 FY2019 | Dec 31, 2019 | 7.0% | −10.3 |
| Q3 FY2019 | Sep 30, 2019 | 18.1% | +5.4 |
| Q2 FY2019 | Jun 30, 2019 | 16.8% | +8.5 |
| Q1 FY2019 | Mar 31, 2019 | -4.4% | −10.0 |
| Q4 FY2018 | Dec 31, 2018 | 17.3% | +22.1 |
| Q3 FY2018 | Sep 30, 2018 | 12.7% | +24.6 |
| Q2 FY2018 | Jun 30, 2018 | 8.3% | +12.8 |
| Q1 FY2018 | Mar 31, 2018 | 5.6% | +26.7 |
| Q4 FY2017 | Dec 31, 2017 | -4.9% | −3.1 |
| Q3 FY2017 | Sep 30, 2017 | -11.9% | – |
| Q2 FY2017 | Jun 30, 2017 | -4.6% | – |
| Q1 FY2017 | Mar 31, 2017 | -21.1% | – |
| Q4 FY2016 | Dec 31, 2016 | -1.7% | – |
See a number that looks wrong?